CYP24A1 splice variants-Implications for the antitumorigenic actions of 1,25-(OH)2D3 in colorectal cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 1-2, 2010, Pages 76-79

  Horvath H C ^a   Khabir, Z ^b   Nittke, T ^b   Gruber, S ^c   Speer, G ^a   Manhardt, T ^b   Bonner, E ^d   Kallay, E ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Universitatsklinik fur Dermatologie   (Austria)

^d Hospital Rudolfstiftung   (Austria)

Author keywords

Colorectal cancer; CYP24A1; Splicing variant; Vitamin D3

Indexed keywords

25 HYDROXYCOLECALCIFEROL 24 HYDROXYLASE; CALCIFEDIOL; CALCITRIOL; OXYGENASE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; COLECALCIFEROL 24 HYDROXYLASE; CYP24A1 PROTEIN, HUMAN; PRIMER DNA; PROTEIN BINDING; STEROID MONOOXYGENASE; STEROL;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; COLON; COLORECTAL CANCER; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; RNA TRANSLATION; ALTERNATIVE RNA SPLICING; BIOSYNTHESIS; CHEMISTRY; COLORECTAL TUMOR; GENETICS; METABOLISM; MIDDLE AGED; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COLON; COLORECTAL NEOPLASMS; DNA PRIMERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN BINDING; STEROID HYDROXYLASES; STEROLS; VITAMIN D3 24-HYDROXYLASE;

EID: 77954759961     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.03.080     Document Type: Article

References (13)

1. Anderson M.G., Nakane M., Ruan X., Kroeger P.E., Wu-Wong J.R. Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother. Pharmacol. 2006, 57:234-240.
2. Townsend K., Banwell C.M., Guy M., Colston K.W., Mansi J.L., Stewart P.M., Campbell M.J., Hewison M. Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin. Cancer Res. 2005, 11:3579-3586.
3. Parise R.A., Egorin M.J., Kanterewicz B., Taimi M., Petkovich M., Lew A.M., Chuang S.S., Nichols M., El-Hefnawy T., Hershberger P.A. CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer. Int. J. Cancer 2006, 119:1819-1828.
4. Miller G.J., Stapleton G.E., Hedlund T.E., Moffat K.A. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. Clin. Cancer Res. 1995, 1:997-1003.
5. Jones G., Ramshaw H., Zhang A., Cook R., Byford V., White J., Petkovich M. Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human nonsmall cell lung carcinomas. Endocrinology 1999, 140:3303-3310.
6. Mimori K., Tanaka Y., Yoshinaga K., Masuda T., Yamashita K., Okamoto M., Inoue H., Mori M. Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer. Ann. Oncol. 2004, 15:236-241.
7. Ren S., Nguyen L., Wu S., Encinas C., Adams J.S., Hewison M. Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis. J. Biol. Chem. 2005, 280:20604-20611.
8. Muindi J.R., Nganga A., Engler K.L., Coignet L.J., Johnson C.S., Trump D.L. CYP24 splicing variants are associated with different patterns of constitutive and calcitriol-inducible CYP24 activity in human prostate cancer cell lines. J. Steroid Biochem. Mol. Biol. 2007, 103:334-337.
9. Bareis P., Kallay E., Bischof M.G., Bises G., Hofer H., Potzi C., Manhardt T., Bland R., Cross H.S. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3). Exp. Cell Res. 2002, 276:320-327.
10. Albertson D.G., Ylstra B., Segraves R., Collins C., Dairkee S.H., Kowbel D., Kuo W.L., Gray J.W., Pinkel D. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet. 2000, 25:144-146.
11. Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K., Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F., Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L., Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E., Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C., Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J., Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H., Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W., Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A., Whiting M., Madan A., Young A.C., Shevchenko Y., Bouffard G.G., Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M., Butterfield Y.S., Krzywinski M.I., Skalska U., Smailus D.E., Schnerch A., Schein J.E., Jones S.J., Marra M.A. Generation and initial analysis of more than 15000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:16899-16903.
12. Omdahl J. The 25-hydroxyvitamin D 24-hydroxylase. Vitamin D 2005, 85-104. Elsevier Academic Press, Los Angeles. D. Feldman (Ed.).
13. Lechner D., Kallay E., Cross H.S. 1 Alpha,25-dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells. Mol. Cell. Endocrinol. 2007, 263:55-64.